Science Overview Replicor is a clinical-stage company developing novel NUCLEIC ACID-BASED POLYMERS (NAPs): oligonucleotides whose antiviral activity is strictly dependent on the polymer chemistry of oligonucleotides which can be preserved independently of the sequence of nucleotides present. NAPs have a very important safety advantage over all other existing oligonucleotide-based drugs such as aptamers, antisense oligonucleotides …
http://www.replicor.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Thursday
LOAD TIME
1.4 seconds
Replicor Inc.
500 Car●●●●●●●vd West
La●●al , QC, H7V 5B7
CA
View this contact
Replicor Inc.
Bazinet, Leo
6100 av●●●●●●●almount
Mon●●●eal , QC, H4P 2R2
CA
View this contact
Replicor Inc.
Bazinet, Leo
6100 av●●●●●●●almount
Mon●●●eal , QC, H4P 2R2
CA
View this contact
BUY YOUR DOMAIN
25
YEARS
6
MONTHS
8
DAYS
NETWORK SOLUTIONS, LLC.
WHOIS : whois.networksolutions.com
REFERRED : http://networksolutions.com
PAGES IN
THIS WEBSITE
12
SSL
EXTERNAL LINKS
0
SITE IP
64.254.236.214
LOAD TIME
1.426 sec
SCORE
6.2
Home | Replicor | replicor.com Reviews
https://replicor.com
Science Overview Replicor is a clinical-stage company developing novel NUCLEIC ACID-BASED POLYMERS (NAPs): oligonucleotides whose antiviral activity is strictly dependent on the polymer chemistry of oligonucleotides which can be preserved independently of the sequence of nucleotides present. NAPs have a very important safety advantage over all other existing oligonucleotide-based drugs such as aptamers, antisense oligonucleotides …
replicor.com
Latest News | ReplicorReplicor announces publication of its REP 101 and REP 102 studies demonstrating the therapeutic effect of NAPs and the achievement of functional control off treatment in human patients with chronic hepatitis B infection. | Replicor
http://replicor.com/about-us/news
August 2, 2016. Replicor announces publication of its REP 101 and REP 102 studies demonstrating the therapeutic effect of NAPs and the achievement of functional control off treatment in human patients with chronic hepatitis B infection. June 7, 2016. Replicor announces publication of its REP 101 and REP 102 studies demonstrating the therapeutic effect of NAPs and the achievement of functional control off treatment in human patients with chronic hepatitis B infection. April 4, 2016. February 16, 2016.
Publications | Replicor
http://replicor.com/science/publications
Peer Reviewed Publications on Replicor's NAP Technology. Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection. Vaillant A. Antiviral Research 2016 133: 32-40. Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg Chronic Hepatitis B Infection. Al-Mahtab M, Bazinet, M, Vaillant A. PLOS ONE 2016 11: e0156667. Matsumura...
Investors | Replicor
http://replicor.com/about-us/investors
Replicor is a privately funded company. The company is well supported by shareholders that include two New York-based institutional investors.
Management | Replicor
http://replicor.com/about-us/team
Michel Bazinet, M.D. CEO and Chief Medical Officer. Andrew Vaillant, Ph.D. Matthieu Blanchet, Ph.D. Director of Scientific Collaborations. Léo Bazinet, B.A.A. Mr Bazinet has 30 years of experience in administration, marketing and finance in the private sector. He has a Bachelor’s Degree in Business Administration from the University of Quebec in Montreal.
Hepatitis D | Replicor
http://replicor.com/science/hepatitis-d
Hepatitis D, also called hepatitis delta, affects 15 to 20 million patients worldwide and is the most deadly of all forms of hepatitis. HDV infection is always associated with chronic hepatitis B infection (HBV) since the HDV virus needs the surface membrane proteins of the HBV virus (HBsAg) to complete the formation of the HDV virus. NAPs have the potential to be effective against HBV / HDV co-infection. It is expected that the persistence of HBsAg in patients with chronic HDV infection prevents an opti...
TOTAL PAGES IN THIS WEBSITE
12
RepliCon - Úvod
Rádi bychom vám oznámili termín III. Ročníku veletrhu šermu a fantasy Replicon.cz 2015. Pro letošní rok 2015 chystáme opět mnoho změn a novinek. Veletrh bude ale probíhat v podobném formátu jako v roce 2014. Seznam přihlášených exhibičních a plnohodnotných seminářů, stejně jako seznam přednášek pro rok 2015 budeme průběžně zveřejňovat na stránkách veletrhu www.replicon.cz. Prosíme ty z vás, kteří by se rádi na naší akci prezentovali, aby nás kontaktovali na adrese info@replicon.cz. Tel: 724 929 239.
Replicon Group
Growth Consulting, Risk Based Cash Flow Evaluations, Private Equity Advisory. Providing Health Promotion Innovations Based on Mathematical Inference.
Replicon Health Ltd. - Home
Providing Health Promotion Inventions Based on. Our innovation is based on reduced econometric modeling of ultra-complicated biological systems. With created low cost and high return strategy and in line with EMA guidelines. CURRENT 04/2015: * Our 3rd investment round successfully completed - additional issue may be offered * * Due to novel positive results, RH activators have been asked to be used as a reference agent in certain pre-clinical anti-inflammatory models *.
MyDomain.com - FUTURE HOME OF A MYDOMAIN.COM-HOSTED WEBSITE
FUTURE HOME OF A MYDOMAIN.COM-HOSTED WEBSITE. You are viewing this page because no homepage (index.html) has been uploaded.
Replicopy Digital Media Center l CD Duplication l DVD Duplication
Book Us For Your. Whether you need millions next month, thousands by next week, or just a handful today, we guarantee perfect reproduction of your master, beautiful on-disc printing, and the quickest turnaround times in the industry. Contact our sister company RDM Productions. For all your production and equipment needs! Our newsletter is awesome. Subscribe and get the latest updates. Click here. Stars based on 8. February 18, 2015. New Information For Closed Captioning! August 11, 2014. August 4, 2014.
Home | Replicor
350 million people have chronic hepatitis B. We’re developing the cure. Replicor has focused its efforts on developing a cure for HBV and HDV. Three POC Phase II clinical trials have demonstrated that NAP therapy (including REP 2139-Ca with immunotherapy (Pegasys or Zadaxin ) is well tolerated and results in antiviral responses that include:. The elimination (up to. Reduction to LLOQ) of HBsAg in the blood seroconversion for both HBsAg and HBeAg. The elimination (up to 6.
Radiator and oil cooler manufactures & engineers | Replicore New Zealand
Replicore - A family business. We enjoy unique challenges. What we can offer. Are you in need of radiator cores? Is to manufacture radiator and oil cooler cores for vintage cars, antique cars and warbirds. A legacy of quality. Replicore manufacturers to original specifications where practical or can offer an alternative soluction if required. Browse through a range of projects we have worked on over the years. Warbirds, vintage cars, antique cars and much more. To read our story.
:-)
Sierpień 6, 2014. Dodaj komentarz Anuluj pisanie odpowiedzi. Twój adres e-mail nie zostanie opublikowany. Pola, których wypełnienie jest wymagane, są oznaczone symbolem *. Możesz użyć następujących tagów oraz atrybutów. A href= title= abbr title= acronym title= b blockquote cite= cite code del datetime= em i q cite= strike strong.
RepliCounts: Design for Selling Digital Art Online
RepliCounts: Design for Selling Digital Art Online. Financial accounts that can replicate. And inherit hundreds of services at birth, will support artists by mass sponsorship, and open doors to new business models. COMMENT HERE for visibility. You can comment on any post - but we future-dated this one so it stays here on top, where readers can find your comment more easily. Anonymous comments OK, all comments moderated. Posted by John S. James. Cure research is now mainstream. Posted by John S. James.
RepliCounts: New ways to pay artists online
中国 español عربي português русский 日本 Deutsch française italiano. New ways to pay artists online. To start, see the 550-word explanation of RepliCounts, at www.replicounts.ORG. For an introduction to mass sponsorship for selling digital art, see the 5-page Introduction and Summary. Especially the first 4 paragraphs). You can try this demo software by clicking the 'Manage' button, below. Also see our money search engine (and a link to its blogroll) at www.replicounts.org. How to use this page:. Our context...
